109 related articles for article (PubMed ID: 14728832)
1. [Preliminary research of the relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung squamous cell carcinoma].
Wang T; Sun YE; Tian JH; Liu XB; Yao SL; Wang K
Zhonghua Wai Ke Za Zhi; 2003 Dec; 41(12):913-6. PubMed ID: 14728832
[TBL] [Abstract][Full Text] [Related]
2. [Relationship between overexpression of facilitative glucose transporter-1 and fluorodeoxyglucose uptake in primary human lung adenocarcinoma].
Wang T; Sun YE; Yao SL; Tian JH; Liu XB; Wang K
Zhonghua Wai Ke Za Zhi; 2004 Aug; 42(16):968-71. PubMed ID: 15363231
[TBL] [Abstract][Full Text] [Related]
3. The relationship between the glucose transporter type 1 expression and F-fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Hiyoshi Y; Watanabe M; Imamura Y; Nagai Y; Baba Y; Yoshida N; Toyama E; Hayashi N; Baba H
Oncology; 2009; 76(4):286-92. PubMed ID: 19262068
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma.
Kunkel M; Reichert TE; Benz P; Lehr HA; Jeong JH; Wieand S; Bartenstein P; Wagner W; Whiteside TL
Cancer; 2003 Feb; 97(4):1015-24. PubMed ID: 12569601
[TBL] [Abstract][Full Text] [Related]
6. Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung.
Song YS; Lee WW; Chung JH; Park SY; Kim YK; Kim SE
Lung Cancer; 2008 Jul; 61(1):54-60. PubMed ID: 18191496
[TBL] [Abstract][Full Text] [Related]
7. [Correlation between FDG PET /CT and the expression of glutl and ki-67 antigen in esophageal cancer].
Mu DB; Wang SP; Yang WF; Fu Z; Chen XX; Sun XR; Yu JM
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):30-3. PubMed ID: 17575690
[TBL] [Abstract][Full Text] [Related]
8. FDG uptake and glucose transporter type 1 expression in lymph nodes of non-small cell lung cancer.
Chung JH; Lee WW; Park SY; Choe G; Sung SW; Chung JK; Lee MC; Kim SE
Eur J Surg Oncol; 2006 Nov; 32(9):989-95. PubMed ID: 16859874
[TBL] [Abstract][Full Text] [Related]
9. [Fluorine-18 fluorodeoxyglucose uptake in patients with primary lung cancer].
Wang T; Sun Y; Zhou N; Yao S; Wang R; Yin D
Zhonghua Wai Ke Za Zhi; 2002 Jun; 40(6):437-40. PubMed ID: 12139802
[TBL] [Abstract][Full Text] [Related]
10. Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
Tian M; Yu L; Zhang Y; Gao X
Acad Radiol; 2012 Apr; 19(4):420-6. PubMed ID: 22444673
[TBL] [Abstract][Full Text] [Related]
11. Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer.
Brown RS; Leung JY; Kison PV; Zasadny KR; Flint A; Wahl RL
J Nucl Med; 1999 Apr; 40(4):556-65. PubMed ID: 10210213
[TBL] [Abstract][Full Text] [Related]
12. Expression of the neutral amino acids transporter ASCT1 in esophageal carcinomas.
Younes M; Pathak M; Finnie D; Sifers RN; Liu Y; Schwartz MR
Anticancer Res; 2000; 20(5C):3775-9. PubMed ID: 11268453
[TBL] [Abstract][Full Text] [Related]
13. Expression of facilitative glucose transporter isoforms in lung carcinomas: its relation to histologic type, differentiation grade, and tumor stage.
Ito T; Noguchi Y; Satoh S; Hayashi H; Inayama Y; Kitamura H
Mod Pathol; 1998 May; 11(5):437-43. PubMed ID: 9619596
[TBL] [Abstract][Full Text] [Related]
14. Fluorine-18-alpha-methyltyrosine positron emission tomography for diagnosis and staging of lung cancer: a clinicopathologic study.
Kaira K; Oriuchi N; Otani Y; Shimizu K; Tanaka S; Imai H; Yanagitani N; Sunaga N; Hisada T; Ishizuka T; Dobashi K; Kanai Y; Endou H; Nakajima T; Endo K; Mori M
Clin Cancer Res; 2007 Nov; 13(21):6369-78. PubMed ID: 17975149
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of glucose transporter 1 expression in patients with hypopharyngeal carcinoma.
Mineta H; Miura K; Takebayashi S; Misawa K; Araki K; Misawa Y; Ueda Y
Anticancer Res; 2002; 22(6B):3489-94. PubMed ID: 12552944
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake.
Brown RS; Leung JY; Fisher SJ; Frey KA; Ethier SP; Wahl RL
J Nucl Med; 1996 Jun; 37(6):1042-7. PubMed ID: 8683298
[TBL] [Abstract][Full Text] [Related]
17. Correlation of Glut-1 glucose transporter expression with.
Higashi K; Ueda Y; Sakurai A; Wang XM; Xu L; Murakami M; Seki H; Oguchi M; Taki S; Nambu Y; Tonami H; Katsuda S; Yamamoto I
Eur J Nucl Med; 2000 Dec; 27(12):1778-85. PubMed ID: 11189940
[TBL] [Abstract][Full Text] [Related]
18. Glut-1 and hexokinase expression: relationship with 2-fluoro-2-deoxy-D-glucose uptake in A431 and T47D cells in culture.
Aloj L; Caracó C; Jagoda E; Eckelman WC; Neumann RD
Cancer Res; 1999 Sep; 59(18):4709-14. PubMed ID: 10493529
[TBL] [Abstract][Full Text] [Related]
19. Use of 18F-FDG PET for primary treatment strategy in patients with squamous cell carcinoma of the oropharynx.
Kim SY; Roh JL; Kim MR; Kim JS; Choi SH; Nam SY; Lee SW; Kim SB
J Nucl Med; 2007 May; 48(5):752-7. PubMed ID: 17475963
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of non-small cell lung cancer.
Ohtsuka T; Nomori H; Ebihara A; Watanabe K; Kaji M; Naruke T; Suemasu K; Uno K
Ann Thorac Cardiovasc Surg; 2006 Apr; 12(2):89-94. PubMed ID: 16702929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
